1. Home
  2. REGN vs SE Comparison

REGN vs SE Comparison

Compare REGN & SE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Regeneron Pharmaceuticals Inc.

REGN

Regeneron Pharmaceuticals Inc.

N/A

Current Price

$781.39

Market Cap

79.4B

Sector

Health Care

ML Signal

N/A

Logo Sea Limited each representing one

SE

Sea Limited each representing one

N/A

Current Price

$90.21

Market Cap

77.8B

ML Signal

N/A

Company Overview

Basic Information
Metric
REGN
SE
Founded
1988
2009
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
79.4B
77.8B
IPO Year
1995
2017

Fundamental Metrics

Financial Performance
Metric
REGN
SE
Price
$781.39
$90.21
Analyst Decision
Buy
Strong Buy
Analyst Count
24
11
Target Price
$819.54
$179.54
AVG Volume (30 Days)
617.3K
7.0M
Earning Date
04-16-2026
01-01-0001
Dividend Yield
0.49%
N/A
EPS Growth
8.19
N/A
EPS
41.48
N/A
Revenue
$5,872,227,000.00
N/A
Revenue This Year
$11.69
$25.20
Revenue Next Year
$10.06
$17.80
P/E Ratio
$18.31
$49.15
Revenue Growth
20.82
N/A
52 Week Low
$476.49
$77.05
52 Week High
$821.11
$199.30

Technical Indicators

Market Signals
Indicator
REGN
SE
Relative Strength Index (RSI) 52.19 33.31
Support Level $740.39 N/A
Resistance Level $786.67 $161.37
Average True Range (ATR) 21.05 4.88
MACD -2.04 -1.40
Stochastic Oscillator 68.99 32.57

Price Performance

Historical Comparison
REGN
SE

About REGN Regeneron Pharmaceuticals Inc.

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal and bispecific antibodies with Sanofi, other collaborators, and independently, and has early-stage partnerships that bring new technology to the pipeline, including RNAi (Alnylam) and Crispr-based gene editing (Intellia).

About SE Sea Limited each representing one

Sea started as a gaming business, Garena, but in 2015 expanded into e-commerce. Sea operates Southeast Asia's largest e-commerce company, Shopee, in terms of gross merchandise value. Shopee is a hybrid C2C and B2C marketplace platform operating in Indonesia, Taiwan, Vietnam, Thailand, Malaysia, the Philippines, and Brazil. For Garena, Free Fire is the key revenue generating game. Sea's third business, SeaMoney, provides lending, payment, digital banking, and insurance services.As of March 31, 2025, Forrest Xiaodong Li, the founder, chairman and CEO, owned 59.1% of voting power. Tencent owned 18.5% of issued shares with no voting power.

Share on Social Networks: